ArticlePharmaceuticals (Basel, Switzerland)2024

Development of Syringaldehyde as an Agonist of the GLP-1 Receptor to Alleviate Diabetic Disorders in Animal Models.

Jenpei Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.